You are here

Airsupra

AstraZeneca's Airsupra cuts risk of severe exacerbations by 47% in patients with milder asthma

Fierce Pharma

Mon, 05/19/25 - 10:22 pm

clinical trials

AstraZeneca heads to regulators after Airsupra asthma trial stops early thanks to 'overwhelming efficacy'

Fierce Pharma

Mon, 10/7/24 - 09:50 pm

AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers

Reuters

Mon, 03/18/24 - 11:05 am

Boehringer Ingelheim

Bevespi Aerosphere

Breztri Aerosphere

AstraZeneca and Avillion win approval for new asthma rescue treatment in adults

Endpoints

Wed, 01/11/23 - 10:53 am